---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293358548.md"
description: "Trevi Therapeutics shares are trading higher after BMO Capital initiated its coverage on the stock with an Outperform rating and announced a price target of $36."
datetime: "2026-07-21T14:32:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293358548.md)
  - [en](https://longbridge.com/en/news/293358548.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293358548.md)
---

# 

Trevi Therapeutics shares are trading higher after BMO Capital initiated its coverage on the stock with an Outperform rating and announced a price target of $36.

### Related Stocks

- [TRVI.US](https://longbridge.com/en/quote/TRVI.US.md)
- [BMO.US](https://longbridge.com/en/quote/BMO.US.md)

## Related News & Research

- [Trevi Therapeutics Initiated at Buy on Clean Late-Stage Execution, De-Risked IPF Cough and RCC Pipelines, and Solid Cash Position](https://longbridge.com/en/news/295837729.md)
- [Sei Investments Co. Has $933,000 Holdings in Trevi Therapeutics, Inc. $TRVI](https://longbridge.com/en/news/295765971.md)
- [This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday](https://longbridge.com/en/news/296352846.md)
- [BMO Capital Sticks to Their Buy Rating for Merck & Company (MRK)](https://longbridge.com/en/news/296482637.md)
- [NewEdge Advisors LLC Sells 21,042 Shares of American International Group, Inc. $AIG](https://longbridge.com/en/news/295905855.md)